Skip to main content

Table 2 Clinical characteristics of children

From: Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2–5 years

Characteristic

Age 2–3 years n (%)

Age 4–5 years n (%)

Total n (%)

Comorbidities

Allergic rhinitis

2 (13.3)

2 (13.3)

4 (26.6)

Chronic rhinosinusitis

0 (0.0)

0 (0.0)

0 (0.0)

Eosinophilic esophagitis

0 (0.0)

0 (0.0)

0 (0.0)

Nasal polyposis

0 (0.0)

1 (6.7)

1 (6.7)

Atopic dermatitis

0 (0.0)

2 (13.3)

2 (13.3)

Exacerbations

Clinician-diagnosed asthma – 1 time in past month

1 (6.7)

1 (6.7)

2 (13.3)

Hospitalization – 1 time in past month

0 (0.0)

1 (6.7)

1 (6.7)

Severity

Caregiver rating of child’s asthma severity (last 7 days)

No symptoms

2 (13.3)

5 (33.3)

7 (46.6)

Mild

2 (13.3)

2 (13.3)

4 (26.6)

Moderate

0 (0.0)

2 (13.3)

2 (13.3)

Severe

1 (6.7)

1 (6.7)

2 (13.4)

Clinician rating*of child’s asthma severity (last 3 months)

Very mild

1 (6.7)

0 (0.0)

1 (6.7)

Mild

1 (6.7)

3 (20.0)

4 (26.7)

Moderate

1 (6.7)

4 (26.7)

5 (33.4)

Severe

2 (13.3)

3 (20.0)

5 (33.3)

Current treatment**

ICS

2 (13.3)

4 (26.7)

6 (40.0)

ICS + additional

2 (13.3)

4 (26.7)

6 (40.0)

SABA

4 (26.7)

7 (46.7)

11 (73.4)

Maintenance OCS

2 (13.3)

4 (26.7)

6 (40.0)

  1. ICS inhaled corticosteroids; OCS oral corticosteroids; SABA short-acting beta agonist
  2. *Made by the child’s asthma clinician
  3. **Treatments were not mutually exclusive